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ABSTRACT

CELLULAR AND MATRIX CHANGES IN ARTICULAR CARTILAGE OF THE
DISPROPORTIONATE MICROMELIA MOUSE MODEL OF OSTEOARTHRITIS

Crystal Noelle Smaldone
Department of Physiology and Developmental Biology
Master of Science

Osteoarthritis (OA) is a degenerative joint disease that affects more than 60%
of Americans 65 and older. Because human subjects and samples are not readily
available for research, animal models are an invaluable resource for the study of OA.
Disproportionate micromelia (Dmm) is one such model that develops OA early in life
due to a deletion in the c-propeptide of the Col2a1 gene. Light microscope analysis of
the articular cartilage in Dmm has been completed, but is insufficient to show the
cellular effects of the deletion mutation in Dmm in adequate detail. The present study
explores the changes that occur in the rough endoplasmic reticulum (ER) of
chondrocytes in the articular cartilage of Dmm heterozygous mutants (D/+).
Immunohistochemical analysis in Dmm has shown that type II collagen is absent
extracellularly in articular cartilage of Dmm homozygous mutants and reduced in the

heterozygotes. Because preprocollagens are processed through the endoplasmic
reticulum (ER), it has been hypothesized that due to improper folding this mutation
prevents newly synthesized collagen from leaving the ER, as a result large dilations
are seen in the ER of Dmm mice. Furthermore, matrix area fractions should be
reduced in the D/+ group if indeed type II collagen is not secreted. Data collected
indicated that at 4 months and older, large distensions in the ER disappear. At age 0
months, there is significant dilation in the ER of the D/+ (p=.0013), and at .75 months
significant dilation is also observed (p=.0063). In pooled age groups, the D/+ has a
1.77% greater ER fraction than the +/+ (p=.0022). The matrix area fraction was also
significantly lower in the D/+ compared to the +/+ (p=.0037). Apoptosis was
prominent in older ages, but did not appear to be different between +/+ and D/+ mice.
Because decreased matrix and dilation of ER have been documented in OA, Dmm is a
good model of OA that can be further used to study the molecular changes and
deficiencies that occur in the pathogenesis of OA.
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INTRODUCTION
Articular Cartilage
Articular cartilage is a layer of smooth hyaline cartilage found at the ends of the
long bones. Articular cartilage’s main role is to absorb tensile and compressive stresses
placed on the joints.1-4 This connective tissue is composed of chondrocytes (cartilage
cells) supported by a unique scaffold of collagens, proteoglycans, and non-collagenous
proteins that form the extracellular matrix (ECM). Chondrocytes are the only cell type
found in the articular cartilage and are responsible for synthesizing the ECM proteins.2,5
Because ECM proteins are continually degraded and renewed throughout the life of an
individual, the health and proper function of the chondrocytes is essential for maintaining
articular cartilage.
With regard to dealing with mechanical stresses such as tensile forces, collagens
are a key element of articular cartilage. The 28 collagens that have been described fall
into two major classes: fibril forming and non-fibril forming. Type II collagen, a fibril
forming collagen, is the primary collagen and most abundant protein in articular
cartilage.2,3,6-8 Mature type II collagen is a homotrimer of polypeptides wrapped together
in an alpha-helix. It begins as a pre-procollagen with amino- and carboxy-propeptides
and a signal sequence. Once the signal sequence is cleaved, the procollagen chains
associate in trimers in the endoplasmic reticulum (ER) of chondrocytes. These
procollagens are then processed through the golgi apparatus and secreted into the matrix
where the amino and carboxy-terminus propeptides are cleaved by N- and C-proteinases
respectively.5-12 The final product is a latticework of mature collagen fibrils that gives
articular cartilage its shape and ability to withstand shearing forces. Collagen is further
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supported by proteoglycans, a protein core with polysaccharide chains, and other noncollagenous proteins.2,13-15
Four distinct layers of articular cartilage have been described: superficial,
transitional, middle/deep, and calcified, but clear delineations are not visible

Figure 1: Layers of articular cartilage
The tidemark (TM) (partially enhanced in white) separates uncalcified from calcified
cartilage. No other clear delineations are seen between layers.

between each of these layers (Figure 1). Although the elements of these layers are
essentially the same, each has unique a function, morphology, and composition of matrix
proteins.2 Superficial chondrocytes are flat, spindle-shaped cells that run parallel to the
articular surface along with the ECM.1 Chondrocytes in this layer have a decreased
amount of cytoplasmic organelles. The superficial matrix has an abundance of collagen
and water and a lower proteoglycan content compared to other layers. These properties
allow the superficial zone to give articular cartilage its shape and stiffness. Damage or
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alterations to the superficial zone, manifest as fibrillations, are believed to be a major
starting point in the onset of osteoarthritis.16-19 The layer below the superficial layer is
the transitional layer. Transitional cells are spheroidal and have abundant cytoplasmic
organelles. Matrix fibrils in this layer run oblique to the cell surface, and the matrix has
lower collagen and water content than the superficial layer and increased proteoglycan.
The middle/deep zone has a columnar arrangement of cells, low water content, and high
proteoglycan concentration. Cells of the middle zone lie right along the tide mark
(Figure 1), a border between calcified and uncalcified cartilage. Calcified cartilage is the
layer below the tidemark and superficial to the subchondral bone. Cells in this layer are
usually smaller than in the other layers and have fewer cytoplasmic organelles.2 In the
described layers, cartilage continually undergoes metabolic, biochemical and structural
changes based on stresses placed on the joints. Healthy maintenance of articular cartilage
is dependent on a balance of anabolic and catabolic processes. When this balance is
disturbed, one degenerative joint disease that can develop is osteoarthritis.2,3,18,20,21
Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis, affecting more than
60% of Americans 65 and older.22 This disease is manifest when homeostasis is not
maintained in the articular cartilage. OA is manifest by the breakdown of articular
cartilage, commonly displayed in the knee joints. In the beginning stages of OA, the
articular cartilage degenerates, leading to pain and discomfort. Over time a more
significant portion of the articular cartilage may be lost, which results in spurs on the
bone surface due to hardening of the subchondral bone.19,22 Eventually, the integrity of
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the cartilage may become compromised to the point that it degenerates completely,
leaving bare femoral chondyles rubbing against a bare tibial surface.
Initial changes in the articular cartilage that lead to OA are postulated to occur in
the superficial layer. Fibrillation of the superficial layer increases the permeability of the
articular cartilage, allowing changes in the osmolarity and water content of the cartilage.
As indicated above, as water content increases in cartilage the concentration of
proteoglycans and other matrix proteins decreases. These biochemical changes lead to
decreased tensile strength.13-15,17
OA does not typically reach severe stages in a short period of time. Chondrocytes
are constantly maintaining the articular cartilage by sensing biochemical changes in the
matrix through connections with the ECM. As a result of increased water or decreased
matrix protein concentration, the cells shift to an anabolic state in an attempt to maintain
proper concentrations of matrix proteins and the osmolarity of the tissue.3,13,23 Severe
OA only develops when catabolic processes in the cartilage are disproportionately
increased compared to anabolic processes. In many cases, temporary improvements are
seen in the articular cartilage following onset of OA, and the disease may progress over
many years.20,22 This illustrates a strong age component in the development of OA, but
aging is not the sole cause of OA. Primary OA occurs when a specific disease cause is
unknown (i.e. aging), whereas secondary OA occurs when a specific cause is known:
joint trauma or injury, genetic pre-disposition, infection, and metabolic factors.15,17
Disproportionate micromelia (Dmm)
One specific source of secondary OA is mutation of the Col2a1 gene because it
codes for type II collagen, which, as previously stated, is the most prominent collagen in
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articular cartilage. A large variety of mutations has been documented in Col2a1 with
similar and sometimes identical disease phenotypes including several collagenopathies:
Stickler syndrome,24 Kniest dysplasia, spondyloepithelial dysplasia congenital,6
achondrogenesis,25 osteoarthritis (OA).12 Unfortunately, the use of human subjects for
OA research is limited; therefore, the quest for better treatments of the disease is
hindered. Instead, researchers rely on animal models that carry mutations in Col2a1 to
better understand the molecular mechanisms that lead to the onset and progression of OA.
Murine models, therefore, are a precious resource that facilitates continuing
research to determine the molecular pathways that play a role in the pathogenesis of OA;
one such model is Disproportionate micromelia (Dmm). The mutant gene carries a threenucleotide deletion in the c-propeptide coding region of Col2a1 gene that causes an Asn
to replace what is Lys and Thr in the wild-type.12 As a result of the mutation, the Col2a1
chains are not properly assembled, which leads to defective collagen assembly, leading to
the manifestation of mutant phenotypes. As reviewed above, the c-propeptide is cleaved
upon secretion into the extracellular matrix. In Dmm homozygotes, it is uncertain
whether pro-collagens even form and are secreted.
Two distinct phenotypes are observed in Dmm: homozygous mutant (D/D) and
heterozygous mutant (D/+). D/D mice are characterized by a cleft palate and severe
chondrodysplasia; in fact, the mutation is lethal and the animals die of pulmonary
hypoplasia at birth.26 Heterozygotes have mildly decreased length of limbs, tail, and
body in addition to the onset of OA by four months postpartum.27-30 Since histological
studies demonstrate that D/+ mice develop OA, it has become an invaluable model for
studying the molecular mechanisms that lead to OA in humans.
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Previous studies on D/+ mice provide several clues as to how OA progresses in
articular cartilage. Histological studies on D/+ mice at 3 and 6 months show that the
articular cartilage is thinner, has an increased cell density and decreased matrix fraction
compared with the wild-type.30 The lack of type II collagen in the ECM is the presumed
factor that leads to the manifestation of OA, but the mechanisms that cause a lack of
collagen and increased chondrocyte density in articular cartilage are not known.
Seegmiller et al. recently showed decreased matrix fraction, hypertrophy of
chondrocytes, and dilation of the endoplasmic reticulum (ER) in fetal rib cartilage of
Dmm, suggesting that the decreased matrix fraction may be due to the Col2a1 not being
properly processed and released from the chondrocytes.31 In other studies on other
Col2a1 mutants, OA models, and human OA, a decreased matrix fraction due to OA was
also shown with ER dilation,15,32 increased water content in the matrix,14,15,20 fibrillation
and lesions in the superficial zone,17 increased cell fractions,14 matrix disorganization,30
increased intracellular lipids,15 increased microtubules,15 and cell clustering.14,20
Apoptosis
Apoptosis is another mechanism that is suspected to play a critical role in the
progression of OA.33-36 Apoptosis is programmed cell death in which cells are signaled
to die. Markers for apoptosis include cell shrinkage, membrane blebbing, chromatin
condensation (pycnosis), and DNA fragmentation while the mitochondria appear
relatively normal.37,38 Necrosis and apoptosis are commonly interchanged erroneously,
but necrosis is unprogrammed cell death. Necrotic cells are characterized by swelling of
the cytoplasmic organelles, a trait which is not observed in apoptotic cells.38 In the
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present study, the present study explored apoptosis in Dmm because recent research
suggests that osteoarthritic cartilage may progress through an apoptotic pathway.33,34,36,37
Dmm as a model for osteoarthritis
The proposed study was designed to look for cellular differences at the
ultrastructural level in D/+ compared to age-matched controls. Because, abnormalities
were observed in the ER of D/+ mice in fetal rib cartilage,31 changes in the ER were
specifically observed and quantified in the present study. In addition, cell and matrix
area fractions were quantified across several age groups, and a preliminary survey for
apoptosis was conducted.
It was expected that the cellular ultrastructure of Dmm cartilage would be
significantly different from that of the wild-type (+/+). Apoptosis was anticipated to be
observed more frequently in the Dmm mutant, and at older ages. Also, it was expected
that the ratio of ECM to cells would be lower in D/+, indicating that part of the
pathogenesis of OA in Dmm is due to the lack of collagen matrix. One possible cause of
insufficient ECM is that the Col2a1 alpha chains are not being properly processed to
permit them to leave the endoplasmic reticulum. If the chains are prevented from being
secreted, it was predicted that the ER in D/+ would be dilated compared to the +/+ as
observed in pilot studies and other representations of OA.9,31,32
Therefore, to further validate Dmm as a model of OA, and to further understand
the ultrastructural changes in the pathogenesis of OA, the following objectives were
proposed in D/+ mice:
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Objectives
1.

To quantitatively characterize the ER at the ultrastructural level in articular

cartilage of D/+ mice
2.

To determine the cell and matrix area fractions in D/+ mice at several ages

3.

To determine if degeneration of articular cartilage in D/+ mice may include an

apoptotic pathway.
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METHODS AND MATERIALS
Facilities and Animal Management
The colony of CH3 mice carrying the Col2a1 mutation was maintained at
Brigham Young University’s animal care facility. Mice were kept in steel cages housing
up to four mice and fed a standard mouse diet (Harlen Tecklad 8604) ad libitum.
Between zero days and one month postpartum, identification numbers were assigned to
each mouse, depending on the age of the animal at tissue acquisition.
Genotyping
Tail snips were taken from each animal between zero days and 5 weeks postpartum, and genomic DNA was isolated (ethanol precipitation method) for differentiating
between mutants (D/+, D/D) and controls (+/+). DNA was amplified in 50 ul PCR
reactions using primers that flank the Dmm mutation: forward 5’–
GAGAGGGCTTGGGCAAATGG; reverse 5’– GGTTGGAAAGTGTTTGGGTCC
(Invitrogen). After amplification, DNA was exposed to BcgI restriction enzyme (New
England Biosystems) for 5 hours at 37°C. BcgI cuts upstream and downstream of its
recognition site in Dmm mutants, excising a small 34 bp fragment.39 No recognition site
is present in the wild-type gene so only one band representing the amplified sequence is
seen for wild-type animals. D/+ animals have the wild-type band because they have one
good copy of the Col2a1 gene, and a lower band representing the 34 bp excision. D/D
animals have only one band representing the excision (Figure 2). Restricted DNA was
run on a 2% agarose gel and visualized with a UV transluminator.
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Tissue Acquisition and Processing
Tissues were collected from wild-type
and D/+ animals at various ages (0,
0.75, 1.5, 4, 7, and 9 months). Because
homozygous mutants only survive a
few minutes past birth,26 D/D samples
Figure 2: Schematic diagram of a gel showing how
genotypes were determined.

were only included in the 0 months

age-group. Animals were first asphyxiated in a carbon-dioxide chamber, and the left
knee joints were surgically removed and immediately fixed in 3% phosphate buffered
glutaraldehyde (pH 7.4) overnight in preparation for transmission electron microscopy
(TEM). Following fixation, knee joints from animals 0.75 months and older were
decalcified in 14% EDTA for 5-7 days. Ascorbic acid was the initial decalcifying agent,
and was found to be quite harsh on the tissue and caused morphological destruction of
many cellular organelles including the ER. After fixation, each knee was sagittally cut,
and the tibia and femur were trimmed closer to the joint (Figure 3). Lateral condyles
were discarded, and medial condyles were washed with buffer, and stained with osmium
tetroxide, and stained with uranyl acetate en block, dehydrated in an ethanol series, and
embedded in Spurr’s resin.40 During embedding, careful attention was paid to
orientation, to ensure that the joint would be sectioned in a lateral to medial plane (Figure
3).
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Figure 3: Schematic Diagram of a left knee joint showing how samples were trimmed and sectioned.
blue = light sectioned yellow = TEM sectioned

Light and Electron Microscopy
When polymerization was complete, each sample was trimmed and sectioned
with an ultramicrotome. Light sections were cut 1000 nm thick and stained with 1%
toluidine blue and azure II. Sections were viewed and photographed using an Olympus
light microscope and RT Spot camera respectively (Diagnostic Instruments). Light
sections were collected for orientation purposes and cell and matrix area fraction studies.
To ensure that transmission electron microscopy (TEM) samples did not vary
significantly in depth for analysis, sections for electron microscopy were collected only
after each sample had been light sectioned 42 µm beyond the cruciate ligament. Samples
in the 0 months age-group were too small to section 42 µm, so samples were only
sectioned until the full femoral head was visible. After sectioning for light microscopy,
the blocks were trimmed to a small trapezoid for TEM (Figure 4). TEM sections were
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cut 80 nm thin, transferred onto copper, carbon and formvar-coated grids, and poststained with Reynold’s lead citrate.41 Ultra-thin sections were examined using an FEI
T12 TEM and photographed using a Gatan MultiScan 794 digital camera at 1650X.
TEM survey photos were collected using film photography because a greater area can be
photographed than with digital photography.
Figure 4: Light
micrograph of the
knee joint indicating
how samples were
trimmed for TEM

Microscopic Analysis
ER Area Fraction
Between 40-100 cells from each sample were randomly marked and photographed
(Figure 5A) using the TEM for ER area fractions. Cells were divided into superficial and
middle depths for data collection. (Data was not collected from cells in the calcified
layer.) Both depths may have included some cells from the transitional layer because no
visible delineation was observed between cartilage layers. The ER of each cell was
traced using Image J (National Institutes of Health) scientific analysis program (Figure
5B). Threshold values were then adjusted so that Image J would automatically recognize
12

and measure each traced portion (Figure 5C); areas were recorded in µm2. Total cell and
nucleus areas were determined in the same manner. Using Microsoft Excel, the nucleus
area was subtracted from the total cell area to determine the area of cytoplasm. Total ER
area for each sample was divided by the cytoplasmic area and multiplied by 100 to
determine what percent of the cytoplasm was ER (ER area fraction of the cell). ER
fractions were used because the same depth location of each cell could not be guaranteed.

Figure 5: Diagram illustrating ER area fraction analysis and how the area of different cellular components
was determined. A) TEM of a chondrocyte. B) TEM with ER traced using Image J. C) Threshold adjusted
photo showing individual particles recognized and measured by Image J. N=nucleus ECM = matrix
µm bar = 2 µm

Cell and Matrix Area Fractions
Light micrographs for each sample were photographed using a Spot RT Color
Camera (Diagnostic Instruments). An area 158µm long and 72µm wide was selected on
each photo and used to determine cell and matrix area fractions (Figure 6A). Each photo
was darkened so that cells would be more visible (Figure 6B). Cells in each photograph
were traced as described previously, and the traced areas were threshold adjusted (Figure
6C). Image J automatically measured and recorded cell area fractions (total area
occupied by cells). Any or all parts of cells visible in the light micrographs were

13

included in the cell fraction. Matrix area fraction was determined by subtracting cell area
fractions from 100.
Apoptosis
Samples taken at 0.75 months and 7
months were viewed with the TEM at
1850X. Three random sections and areas
were chosen for each sample and the
number of cells in the visual field was
counted for a total of six replicates. All
cells that could possibly be dying were
marked and viewed as digital
micrographs to look for signs of
apoptosis: cell shrinkage, condensed

Figure 6: Diagram illustrating how cell and
matrix area fractions were determined A) Area
size used for measurement (158µmX72µm). B)
Darkened micrograph for tracing. C) Threshold
adjusted micrograph measured by Image J.

chromatin, and membrane blebbing. The
number of cells that met these criteria

was recorded.
Statistical Analysis
A three way repeated measures analysis of variance (ANOVA) was used to
determine if mean ER area fractions were significantly different across age, genotype,
and depth. Significance of cell and matrix area fractions across genotype and age was
determined through a two way repeated measures ANOVA. In addition to standard pvalues, a Tukey adjusted p-value is listed. The Tukey p-value is a conservative
adjustment that reduces the chance of error. To increase sample size, +/+ data from 7 and
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9 month old animals was pooled; D/+ data from 7 and 9 month age groups was also
pooled. Before pooling it was previously determined that data from both age groups
were not statistically significant (p > .99). The pooled age group will be referred to as 7
months for the remainder of the study. All statistical analysis was conducted using SAS
® 9.1, SAS Institute Inc., Cary, NC, USA.
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RESULTS
Cell and Matrix Area Fractions
Genotype comparison for all ages
Data from all age groups were pooled to compare differences across genotype only. The
+/+ animals (ages combined) had an average cell fraction of 23.3% and average matrix
fraction of 76.8%. Compared to these percentages, the D/+ had a higher cell and lower
matrix area fraction by 6.5% (Figure 7) p<.004 (Table 1). Light micrographs of articular
cartilage stained with toluidine blue (Figure 8) and low magnification (survey) TEMs
display this difference visually (Figure 9).

Table 1
Area Fraction Comparison by Genotype (Ages Combined)
Genotype Comparison
% Difference
p-value
+/+
D/+
6.51
0.0037

Average Area Fractions by Genotype
120
100

%

80
matrix fraction

60

cell fraction

40
20
0
+/+

D/+
Genotype

Figure 7: Area fractions by genotype show higher cell area fractions and a lower
matrix area fractions in the D/+ compared to controls (all ages pooled)
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Figure 8: Light micrographs of articular cartilage at all ages (indicated at far left) stained with
toluidine blue. D/+ mice have a visibly higher cell and lower matrix fraction. Cells appear larger in
D/+ mice compared to +/+ mice.
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18
Figure 9: Transmission electron micrographs for all ages (indicated at top right). At 0 months cells are larger and matrix fraction appears lower
in D/+ mice compared to +/+. At 1.5 months more lipids and degenerating mitochondria are visible. At 7 months more necrotic cells are visible.
Collagen fibrils appear normally distributed in all ages and genotypes.

Genotype comparison within ages
At zero months, the average cell fraction in +/+ mice was 35.2%, 43.35% in D/+
mice, and 42.44% in D/D mice. While both the homozygous mutant and the
heterozygote showed a higher cell and lower matrix area fraction compared to the +/+
(Figure 10, Figure 11) the comparisons between each genotype showed no significant
differences (Table 2). Visual differences were apparent in the matrix composition at 0
months (Figure 15).
In +/+ animals at 0.75 months, the cell and matrix fractions were 22.4% and
77.6% respectively. D/+ animals had a higher cell fraction (34.4%) (Figure 10) and
lower matrix fraction (65.6%) (Figure 11) compared to the age-matched controls (12%
difference). Unadjusted, the difference is shown to be significant (p=.018), and with the
conservative Tukey adjustment, no significance is demonstrated (p=.26) (Table 2).
In +/+ animals at 1.5 months, the cell and matrix fractions were 24.25% and
75.75% respectively. D/+ animals had a higher cell fraction (29.35%) (Figure 10) and
lower matrix fraction (70.65%) (Figure 11) compared to the age-matched controls (5.1%
difference). Unadjusted and adjusted p-values show no statistical significance (p=.27, padj=.96) (Table 2).
In +/+ animals at 4 months, the cell and matrix fractions were 17.03% and
82.97% respectively. D/+ animals had a higher cell fraction (21%) (Figure 10) and lower
matrix fraction (79%) (Figure 11) compared to the age-matched controls (3.97%
difference). Unadjusted and adjusted, p-values show no statistical significance (p=.29,
p-adj=.97) (Table 2).
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In +/+ animals at 7 months, the cell and matrix fractions were 20.2% and 79.8%
respectively. D/+ animals had a higher cell fraction (24.8%) (Figure 10) and lower
matrix fraction (75.2%) (Figure 11) compared to the age-matched controls (4.6%
difference). Unadjusted and adjusted, p-values show no statistical significance (p=.31, padj=.98) (Table 2).
All D/+ animals show higher cell area fractions and lower matrix area fractions
consistently in each age group. Within age groups, statistical significance could not be
demonstrated for differences except at 0.75 months, but it should be noted that a trend
exists. The ER fractions data with all ages combined does in fact show a significant
difference (p<.004).

Table 2
Age
(months)
0
0.75
1.5
4
7

Area Fraction Comparisons by Genotype within Ages
Genotype
Cell Fraction
Matrix Fraction
Comparison
% Difference % Difference
p-value
8.15
0.086
+/+
D/+
-8.15
+/+
D/D
-7.24
7.24
0.20
D/+
D/D
0.91
-0.91
0.85
0.018
+/+
D/+
-10.4
10.4
+/+
D/+
-5.1
5.1
0.27
+/+
D/+
-3.97
3.97
0.29
4.6
0.31
+/+
D/+
-4.6
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Tukey p-value
.69
0.37
0.98
0.25
0.96
0.97
0.98

Cell Area Fractions
100

% Cells

80
+/+

60

D/+
40

D/D

21

20
0
0

0.75

1.5

4

7

Age (months)

Figure 10: Bar graphs for cell area fractions at each age
At 0.75 months, D/+ mice have a significantly higher cell fraction compared to +/+ mice.
No significant differences in cell area fractions were observed between +/+, D/+, or D/D mice at any other age.
Cell fractions were always higher in D/+ animals.

Matrix Area Fraction
100

% Matrix

80
+/+

60

D/+
40

D/D

20
22

0
0

0.75

1.5

4

7

Age (months)

Figure 11: Bar graphs of matrix area fractions at each age
At 0.75 months, D/+ mice have a significantly lower matrix fraction compared to +/+ mice.
No significant differences in matrix area fractions were observed between +/+, D/+, or D/D mice at any other age.
Matrix fractions were always lower in D/+ animals.

Age comparison within genotypes
Cell and matrix area fractions were also compared within genotypes at various
ages. In +/+ animals, most of the differences were not significant. Cell and matrix area
fractions in the +/+ animal at 0 months, however, were significantly different from all
other ages in the +/+ genotype (Table 3). In the D/+, most of the significant differences
were seen in the 0 days age group. Cell and matrix area fractions in ages 1.5, 4, and 7
months were found to be significantly different from fractions at 0 months (Table 4,
Figure 12, Figure 13). Cell and matrix area fractions from D/+ mice 4 and 7 months old
were also significantly different from fractions of D/+ mice 0.75 months old (Table 4).
No significant difference was observed in cell and matrix area fractions between the D/+,
0 month and 0.75 months animals (Table 4).
A consistent trend is seen in the cell and matrix fractions as the animals age. The
+/+ cell fraction is always lower and the matrix fraction is always higher than D/+ mice,
and with age the cell fraction consistently decreases and the matrix fraction increases
irrespective of genotype (Figure 12, Figure 13).
Table 3

Genotype

Area Fraction Comparisons in +/+ Mice across Ages
Compared
Ages(months)
% Difference
p-value Tukey p-value

0
+/+

0.75
1.5
4

0.75
1.5
4
7
1.5
4
7
4
7
7

12.8
10.95
18.17
15
-1.85
5.37
2.2
7.22
4.05
-3.17
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0.013
0.028
0.0007
0.0049
0.68
0.20
0.62
0.095
0.37
0.44

0.20
0.35
0.015
0.091
1
0.92
1
0.72
0.99
1

Table 4
Area Fraction Comparisons in D/+ Mice across Ages
Compared
Ages(months)
% Difference
p-value Tukey p-value
0.75
8.95
0.06
0.59
1.5
14
0.0075
0.13
0
4
22.35
0.0001
0.0029
7
18.55
0.0011
0.025
1.5
5.05
0.27
0.97
0.75
4
13.4
0.0056
0.10
7
9.6
0.048
0.50
4
8.35
0.058
0.56
1.5
7
4.55
0.32
0.98
4
7
-3.8
0.36
0.99

Genotype

D/+

Cell Area Fractions by Age
50
40
D/+

20

+/+

%

30

10
0
0

0.75

1.5

4

7

Age

Figure 12: Cell area fraction comparison over time
Over time the cell fraction decreases in +/+ and D/+ mice, and the difference between them becomes
smaller.
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Matrix Area Fractions by Age
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Figure 13: Matrix area fraction comparison over time
Over time the matrix fraction increases in both the +/+ and D/+ mice, and the difference between them
becomes smaller.

ER Area Fraction
Initially the focus of the ER study was to be in animals at ages 6 and 9 months.
Upon completion of preliminary data, it was discovered that the ER dilation previously
documented in other osteoarthritis models 32 was not pronounced in animals examined at
7 and 9 months old. An observable difference was seen at 4 months, so it was
determined that animals younger than 4 months should be included in the study. For this
reason, ages explored extensively include 0, 0.75, 1.5, 4, and 7 months. Furthermore, it is
well established that cells in different zones of articular cartilage are morphologically
distinct,2 so results are included that show ER area fractions at different depths
(superficial and middle) in articular cartilage.
Genotype comparison for all ages
Data from the 0.75, 1.5, 4, and 7 months age groups were pooled to compare
differences across genotype only (Figure 14). The cells from +/+ mice (ages combined)
had an average ER fraction of 8.86% (depths combined). In +/+ animals, superficial cells
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had an average ER fraction of 8.18%, and in middle cells, 9.82%. In D/+ mice, ER area
fractions were significantly increased in middle cells (12.48%) and in the combined depth
analysis (10.62%) (Table 5). No significant difference was detected between ER area
fractions in superficial cells of +/+ and D/+ mice (Figure 14).

Table 5
ER Area Fraction Comparison by Genotype (Ages Combined)
Depth

Genotype Comparison

% Difference

Both
Superficial

+/+

D/+

Middle

p-value

1.77

0.0022

1.26

0.13

2.66

0.0013

% ER (Ages Combined)
14
12
% ER

10
8

+/+

6

D/+

4
2
0
Combined

Superficial

Middle

Depth

Figure 14: Bar graphs of ER fractions (ages combined)
D/+ animals show a significantly higher ER fraction compared to +/+ animals (ages combined) in middle
cells and combined depths analysis.
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Genotype comparison within ages
In combined depths at 0 months, the mean ER fraction for +/+ mice was 12.2%,
15.93% for D/+ mice, and 27.93% for D/D mice. The ER fraction of D/D mice was
significantly higher than the +/+ (p=.008) and the D/+ (p=.017), displaying that the ER is
in fact dilated in D/D animals. The data also show that the aforementioned differences
are more pronounced in superficial cells, and barely significant in middle cells. The +/+
and D/+ mice had ER fractions that were significantly different from each other in middle
cells (p=.011) and combined depths analysis (p=.0028) (Table 6, Figure 15, Figure 16,
Figure 17)

Table 6
ER Area Fraction Comparisons by Genotype at 0 Months
Depth
Combined

Superficial

Middle

Genotype Comparison
+/+
D/+
+/+
D/D
D/+
D/D
+/+
D/+
+/+
D/D
D/+
D/D
+/+
D/+
+/+
D/D
D/+
D/D

% Difference
3.73
15.73
12.01
1.51
14.86
13.34
5.94
16.61
10.67
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p-value
0.011
0.0081
0.017
0.42
0.0069
0.0093
0.0028
0.045
0.12

Tukey pvalue
0.18
0.016
0.035
1
0.014
0.019
0.056
0.089
0.23

Figure 15: Matrix and ER TEM at 0 months.
Red arrow points to decreased collagen fibrils and organization in D/D mice. Blue arrows
show dilation in the ER. In D/D mice this dilation is significant and has a fibrous
appearance.
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% ER within Ages (Combined Depths)
35
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% ER
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+/+
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D/+
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0.75

1.5

4

7

Age

Figure 16: ER Area Fractions for all ages (depths combined)
ER fractions in D/+ mice are higher and significantly different than +/+ mice at 0 and 0.75 months. ER
fractions in +/+ and D/+ mice peak at 0.75 months and subsequently decrease.

% ER within Ages (Middle Depth)
40
35

% ER

30
25

+/+

20

D/+

15

D/D
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5
0
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0.75

1.5

4

7

Age

Figure 17: Bar graphs of ER fractions at all ages in middle cells
ER fractions in D/+ mice are higher and significantly different than +/+ mice at 0 and 0.75 months in
middle cells. ER fractions in +/+ and D/+ mice peak at 0.75 months and susequently decrease. In middle
cells, the ER fraction of D/+ mice drops below the +/+ fraction at 7 months.
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Significant differences were seen in the ER fractions between +/+ and D/+ mice at
0 and 0.75 months (ages combined) (Table 7) in combined depths (Figure 16) and middle
cells (Figure 17). No significant differences between +/+ and D/+ mice were observed at
any age in the superficial cell group (data not included). Furthermore, no significant
differences were seen between the +/+ and D/+ at 1.5, 4, or 7 months (Table 7) in
combined (Figure 16) or middle (Figure 17) ER fractions (Figure 19, Figure 20, Figure
21). The D/+ mice do however have a consistently higher ER area fraction compared to
+/+ mice in combined depths. The ER fraction is actually lower in D/+ mice compared to
the +/+ (not statistically significant) at 7 months in middle cells (Table 7). In addition to
a higher ER fraction, lipids and degenerating mitochondria were seen frequently in D/+
mice at 1.5 months, but not in +/+ mice (Figure 9). Lastly, intracellular filaments were
observed more often in D/+ mice at 0.75 months and 1.5 months compared to +/+
animals (Figure 18, Figure 19).
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Figure 18: TEM of middle chondrocytes at 0.75 months
Red arrows point to dilations in the ER. In D/+ mice this dilation is significant. N=nucleus, ECM=
extracellular matrix, ER=endoplasmic reticulum, G=glycogen
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Figure 19: TEM of middle chondrocytes at 1.5 months
+/+ and D/+ middle chondrocytes at 1.5 months show some dilation in the ER (red arrows),
prominent intracellular filaments. N=nucleus, ECM=extracellular matrix, IF=intracellular
filaments.
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Figure 20: TEM of middle chondrocytes at 4 months
Middle chondrocytes from +/+ and D/+ mice at 4 months show a visible decrease in dilation of the ER
(red arrows). N=nucleus, ECM=extracellular matrix
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Figure 21: TEM of middle chondrocytes at 7 months
No obvious difference is observable between the ER of chondrocytes in +/+ or D/+ mice. Red arrows
point to the ER. N=nucleus, ECM= extracellular matrix
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Table 7
ER Area Fraction Comparisons by Genotype within Ages
Age
Avg. %ER Avg. %ER
Tukey
Depth
p-value
(months)
in +/+
in D/+
p-value
0
12.20
15.93
0.011
0.18
0.75
14.40
18.52
0.0063
0.11
Combined
1.5
7.80
9.64
0.17
0.88
4
6.42
7.10
0.52
1
7
5.45
5.51
0.96
1
0
10.39
11.90
0.42
1
0.75
12.67
14.74
0.28
0.97
Superficial
1.5
6.93
8.25
0.48
1
4
6.23
7.10
0.57
1
7
5.63
6.33
0.71
1
14.01
19.95
0.0028
0.056
0
0.75
16.12
22.30
0.0021
0.044
Middle
1.5
8.67
11.02
0.16
0.88
4
6.62
7.11
0.71
1
7
5.27
4.68
0.72
1

Age comparison within genotypes
Within genotypes and across age groups, ER area fractions in animals from the 0
and 0.75 months ages were significantly higher in both genotypes compared to 1.5, 4, and
7 month old animals (Table 8). ER area fractions in animals at 0 and 0.75 months,
however, were not significantly different from each other in either genotype group. At
1.5 months, ER fractions in the D/+ mice were significantly different from ER fractions
in D/+ mice 4 (p=.046) and 7 (p=.0062) months old. The data also show a consistent
trend. At 3 weeks, the % ER peaks in both genotypes, and progressively decreases, until
the % ER values of +/+ and D/+ mice actually merge (Figure 22). Other qualitative
observations include changes and lesions in the superficial zone (Figure 23, Figure 24).
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Figure 22: ER Area Fraction Changes with Age (depths combined)
The ER fraction is higher in the D/+ at young ages, but as the D/+ animals age, the ER fraction
difference from the +/+ becomes zero in combined depths.
Table 8
ER Area Fraction Comparisons within Genotypes and across Ages
(depths combined)

Genotype

+/+

Compared
Ages(months)
0.75
1.5
0
4
7
1.5
0.75
4
7
4
1.5
7
4
7

% Difference
-2.20
4.40
5.78
6.75
6.60
7.97
8.95
1.38
2.35
0.97

p-value
0.10
0.0042
0.0003
0.0002
0.0002
<.0001
<.0001
0.25
0.084
0.41

0.75
1.5
4
7
1.5
4
7
4
7
7

-2.59
6.29
8.82
10.42
8.88
11.42
13.01
2.53
4.13
1.60

0.060
0.0003
<.0001
<.0001
<.0001
<.0001
<.0001
0.046
0.0062
0.19

0

D/+

0.75
1.5
4
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Tukey
p-value

0.75
0.079
0.0067
0.004
0.0048
0.0004
0.0003
0.96
0.68
1
0.57
0.007
0.0001
<.0001
0.0003
<.0001
<.0001
0.49
0.11
0.91

Figure 23: TEM of Changes in the Superficial Matrix
D/+ chondrocyte and surrounding matrix in articular cartilage at 9 months. Red arrow points
to fibrillation and openings (water or increased permeability) in the most superficial layer.
Inset at lower left corner (bar = 0.5µm) shows a larger view of these openings.
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Figure 24: Lesions in the Superficial Matrix
Chondrocyte and surrounding matrix in articular cartilage at 4 months in D/+. Red arrows point to lesions
in the most superficial layer.
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Apoptosis
Apoptosis was increased in both genotypes at older ages. Within age groups,
however, no obvious differences in the number of dying cells were observed between the
+/+ and D/+ mice (Table 9). In all cases, dying cells were only observed in the calcified
zone of articular cartilage. All cells did have condensed chromatin (Figure 25). Some
necrotic cells may have also been included in the counts. Statistical significance was not
determined.
Table 9
Apotosis Cell Counts in 6 Replicates
Age (months) Genotype
Total # Cells # Dying
+/+
158
0
0.75
D/+
183
1
+/+
132
25
7
D/+
153
22

Figure 25: Apoptotic cell in a D/+ mouse at 9 months. Red arrow points to condensed
chromatin. Collagen fibers are noticebly larger in calcified cartilage.
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DISCUSSION & FUTURE STUDIES
Area Fractions (ER, Matrix, Cell)
Data from cell and matrix area fractions showed that mutants (D/+) invariably had
higher cell fractions and lower matrix fractions compared to +/+ age matched controls if
all ages are combined (Table 1, Figure 7). D/+ mice display a lower matrix fraction (p=
.086) even as early as 0 days, implying that proper matrix synthesis is hindered during
fetal development. This is further evidenced in the perceivable difference in the matrix
appearance in D/D mice at 0 months (Figure 15). D/D mice at 0 months had less visible
collagen, but interestingly it did not have a significantly different matrix fraction from
+/+ controls (p=.2047). Studies on aging and OA in C57 black mice show no change in
the cell fraction (chondrocyte density) with age, but a decrease in OA.42 Unfortunately,
no quantitative data on C57 black mice have been collected to support this claim. The
current study shows decreases in cell fraction with both age and OA (D/+); the decrease
is more rapid in D/+ mice and the cell fraction (chondrocyte density) is simply slightly
higher than +/+ mice at each age (statistically significant at 0.75 months only) (Table 2).
This implies that other proteins and water could be contributors to the statistically normal
matrix fraction, but that the lack of collagen fibers leaves the matrix unable to withstand
tensile and compressive forces placed on the joint. Biochemical studies on the matrix
composition would be beneficial to determine how protein concentrations are changing in
the articular cartilage of D/+ mice as OA advances.
ER area fractions at 0 days further support the idea that there is reduced collagen
because the ER is significantly dilated in the D/D mice (p=.0081) (Figure 15). It is quite
likely that collagen is not secreted from the cells in D/D animals, so less collagen
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surrounds the chondrocytes. Chondrocytes must be protected from the daily compressive
and tensile forces they are exposed to, and in D/D mice this protection is severely
compromised. The data from D/D animals validates the recent observations in fetal rib
cartilage of the Dmm mouse: lower matrix fractions, higher cell fraction, dilated ER, and
meager collagen fibrils in the matrix.31
The relationship between the +/+ and D/+ is a little more vague. Upon
examination with the TEM, no morphological difference in the matrix structure and
organization was documented at 0 days (Figure 15). Within age-groups, the only
significant differences in matrix fractions seen between the +/+ and D/+ mice were at
0.75 months (Table 2). This outcome implies that because D/+ animals have one normal
copy of the Col2A1 gene, at young ages they are still able to maintain a semi-normal
matrix. Both genotypes (+/+ and D/+) at 0 and 0.75 months have a significantly higher
ER fraction compared to older ages (1.5, 4, and 7 months) (Table 8, Figure 22),
suggesting that some of the ER dilation at early stages in life is a normal developmental
occurrence. This is further supported by data on normal human articular cartilage that
shows an extensive ER is characteristic of cells actively synthesizing proteins.43
Compared to the +/+ mice, D/+ animals do have a significantly dilated ER above the
normal dilation at 0 and 0.75 months (p=.0113 and p=.0063 respectively) (Figure 15,
Figure 18), and dilation of the ER is further pronounced in middle cells. Malfunctions in
the protein secretory pathway, like those suspected in Dmm, have been linked to a
phenomenon called ER stress.44 The excessive dilations observed in D/+ mice at 0 and
0.75 months could contribute to ER stress, which is linked to decreased ECM production
and chondrocyte apoptosis.44 A higher ER fraction in D/+ mice compared to +/+ mice
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persists until 7 months post-partum (not statistically significant), which could be a source
of prolonged ER stress.
The significant dilation in the ER at 0 and 0.75 months in D/+ mice, therefore,
suggests 1) that abnormal collagen fibers are being retained inside of the cell to some
degree leading to ER stress and 2) that the excess dilation could be indicative of
compensatory mechanisms that cause the good copy of the Col2a1 gene to overproduce
type II collagen. An excess of normal collagen fibers may be produced at early stages,
and this production slows with age. Mutated fibers could be retained in the ER leading to
distension of the ER and degraded intracellularly as the animal ages, or the mutated fibers
could be secreted and degraded extracellularly. In either case, as the D/+ mice age the
production of normal type II collagen slows, and persistent ER stress compounds the
matrix deficiencies already present due to mutant collagen fibrils. As a result,
insufficient normal matrix is produced in D/+ mice leading to premature OA. This is
further evidenced in the fact that as the animals (+/+ and D/+) age, dilation of the ER in
D/+ mice disappears (Figure 20, Figure 21, Figure 22). Furthermore, trends across age
groups show that as the animals age, the difference in ER area fractions between the +/+
and D/+ merges to 0 by 7 months (p=1) in the combined cell depths (Table 8, Figure 22).
In middle cells at 7 months, although not statistically significant, the ER fraction of the
D/+ is actually lower than the +/+. Because loss of dilations in the ER are suggested to
be a sign of advanced OA,45 it would be beneficial to see if the ER fraction in advanced
OA of D/+ mice (12, 15, and 22 months) actually drops below the ER fraction of +/+
mice.

42

The lower matrix fraction shown in D/+ mice seems to support the idea that
collagen is not properly secreted, causing expansion of the ER (larger cells) as collagen
builds up inside, as previously observed in fetal rib cartilage of Dmm mice.31 The data
for this argument, however, would be indisputable if immuno-electron microscopy were
carried out for Col2A1 in +/+ and D/+ mice at various ages. Helminen described ER
dilations containing a proteinaceous material in a transgenic mouse line missing the type
II pro-collagen gene, and other studies have demonstrated intracellular staining of
Col2A1 in chondrocytes,8,9,11 but no data are available that definitively show excess
staining for Col2A1 in the ER of Col2a1 mutants, including Dmm. Gold labeling would
be one possible way of observing the distribution of Col2A1 intracellularly. Also, if a
monoclonal antibody were developed specifically against the mutant collagen in Dmm,
the distribution of normal and mutant fibrils could be documented.
Apoptosis
Currently an on-going debate exists about the relevance of apoptosis in OA.
Many suggest that apoptosis is a key hallmark of OA,33-35,37 while others argue adamantly
against it.46-48 In the present study, apoptosis was more prevalent in older animals than in
younger ones in both the +/+ and D/+ groups (Table 9). Furthermore, apoptotic cells
were only observed in the calcified layer of articular cartilage. Both of these preliminary
observations suggest that apoptosis is not a widespread phenomenon in OA in Dmm
mice, consistent with findings on human osteoarthritic articular cartilage.48 The data
presented here are not sufficient to confirm or reject the presence of apoptosis as a sign of
OA in Dmm. Additional data should be collected, especially since ER stress is suggested
to lead to apoptosis,44 in a light microscopy study using immunohistochemistry for
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biomarkers of apoptosis. Two methods that could be used are terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) and insitu oligo ligation (ISOL).
Neither technique is without flaws,46 therefore using both methods would provide robust
evidence to support or reject the presence of apoptosis in OA of Dmm mice.
Summary
The data herein further validate Dmm as a model for OA. Furthermore, this study
supports previous histological changes shown in the articular cartilage of Dmm30 and
recent changes observed in the fetal rib cartilage of Dmm.31 Finding is the present study
also suggest that the protein secretory pathway of Col2A1 in D/+ mice does not function
properly which leads to a deficient matrix and premature OA. ER stress could be a major
factor in the premature onset of OA in Dmm, but further studies on the composition of
proteins in the ER and matrix are necessary to definitively conclude that type II collagen
is retained in the ER. TEM characterizing the ER and cell structure should also be
conducted at older ages in Dmm to show changes in advanced OA. Lastly,
immunohistochemistry for apoptosis and other biomarkers of OA needs to be conducted
on Dmm mice at various ages to further elucidate the pathological changes of OA.
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